Please login to the form below

Not currently logged in
Email:
Password:

anaemia

This page shows the latest anaemia news and features for those working in and with pharma, biotech and healthcare.

Celgene files luspatercept ahead of key merger vote

Celgene files luspatercept ahead of key merger vote

syndromes (MDS)-associated anaemia and beta-thalassemia-associated anaemia. ... Filing for MDS is based on the phase 3 MEDALIST trial in adults with ring sideroblast (RS+) myelodysplastic syndromes (MDS)-associated anaemia with very low, low, or

Latest news

More from news
Approximately 7 fully matching, plus 142 partially matching documents found.

Latest Intelligence

  • China: AstraZeneca’s new engine for growth and innovation China: AstraZeneca’s new engine for growth and innovation

    FibroGen in China for patients with anaemia in chronic kidney disease.

  • Leo has its eyes on the prize Leo has its eyes on the prize

    major depressive disorder and iron-deficiency anaemia.

  • Deal Watch - May 2017 Deal Watch - May 2017

    It is not known why in December 2015 the territorial rights granted to Mitsubishi for vadadustat for treatment of anaemia, were limited to Japan, SE Asia and India.  From a ... 1, 050. Akebia (US). Otsuka (JP). Licence expansion selected countries.

  • Deal Watch December 2016 Deal Watch December 2016

    1, 000. Akebia (US). Otsuka (Japan). Licence (US). Vadadustat: oral hypoxia-inducible factor (HIF) stabiliser in phase III for anaemia of chronic kidney disease.

  • Focusing on value Focusing on value

    in Brazil, involving the iron deficiency related anaemia treatment Anemidox/Confer and liver protector Hepabionta.

More from intelligence
Approximately 0 fully matching, plus 13 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Joined-up thinking on anaemia

    Iron deficiency anaemia is very common in inflammatory bowel disease (IBD) and can seriously reduce people’s quality of life, but it’s often under-treated. ... Pharmacosmos is committed to improving the lives of patients with iron deficiency anaemia.

  • Living with Crohn's disease: a patient perspective

    It’s also a very individual condition. The most common symptoms are not only diarrhoea, but also tiredness and fatigue, abdominal pain, mouth ulcers, anaemia, loss of appetite, and weight loss.

  • Patient Power: Too Much of a Good Thing?

    It commonly causes abdominal pain, diarrhoea, weight loss and vomiting but because it affects the immune system it can cause other problems such as anaemia, arthritis, lack of concentration, tiredness and

  • Dovetail

    Joined-up thinking on anaemia. ... Iron deficiency anaemia is very common in inflammatory bowel disease (IBD) and can seriously reduce people’s quality of life, but it’s often under-treated.

More from PMHub
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics